Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Yu. P. Milovanov"'
Autor:
L Yu Milovanova, I A Dobrosmyslov, Yu S Milovanov, V V Fomin, M V Taranova, V V Kozlov, S Yu Milovanova, E I Kozevnikova
Publikováno v:
Терапевтический архив, Vol 90, Iss 6, Pp 48-54 (2018)
Aim of the study was to explore the role of the FGF-23/sKlotho/sclerostin ratio disturbance in the determining of cardiovascular risk in end stage renal disease (ESRD) patients, receiving treatment with regular hemodialysis (НD) or hemodiafiltration
Externí odkaz:
https://doaj.org/article/6dbeca9c0bd04b23b27d05d117b7b282
Autor:
Yu S Milovanov, I A Dobrosmyslov, S Yu Milovanova, M V Taranova, L Yu Milovanova, V V Fomin, V V Kozlov
Publikováno v:
Терапевтический архив, Vol 90, Iss 6, Pp 89-91 (2018)
The study demonstrated the results of the comparative analysis of various types of renal replacement therapy effects on the quality of life patients with terminal stage of chronic kidney disease on the basis of standardized questionnaires. It has bee
Externí odkaz:
https://doaj.org/article/cc242dfc855943a49b65529ddbbc8488
Publikováno v:
Терапевтический архив, Vol 88, Iss 6, Pp 95-100 (2016)
The review considers the current views of the mechanisms of hyperphosphatemia in patients with chronic renal failure. It shows indications for the use of different classes of phosphate-binding drugs to correct hyperphosphatemia.
Externí odkaz:
https://doaj.org/article/9aaf963a198345c0aa4d5c81ddec11c6
Publikováno v:
Терапевтический архив, Vol 88, Iss 6, Pp 21-25 (2016)
Aim. To investigate the impact of anemia correction with erythropoiesis stimulants on the serum level of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease (CKD). Subjects and methods. 64 patients ag
Externí odkaz:
https://doaj.org/article/ae868a7ea71d4d8ea41fa2662927e7b2
Publikováno v:
Терапевтический архив, Vol 88, Iss 4, Pp 41-45 (2016)
Aim. To study whether the excessive production of serum fibroblast growth factor 23 (FGF-23) may be reduced with phosphate-binding agents to treat hyperphosphatemia in patients with Stage VD chronic kidney disease (CKD). Subjects and methods. The inv
Externí odkaz:
https://doaj.org/article/ff32731fd6ef40799dbc050f41a73ca8
Autor:
L Yu Milovanova, Yu S Milovanov, D V Kudryavtseva, M M Markina, S Yu Milovanova, L V Kozlovskaya, M V Lebedeva, V D Beketov, S V Moiseev, N A Mukhin, V V Fomin, A A Svistunov
Publikováno v:
Терапевтический архив, Vol 87, Iss 6, Pp 10-16 (2015)
Aim. To analyze changes in the serum concentrations of the morphogenetic proteins fibroblast growth factor 23 (FGF-23) and Klotho, as well as sclerostin, an osteocyte-secreted glycoprotein, in relation to the degree of hypertension, left ventricular
Externí odkaz:
https://doaj.org/article/f5bbc7eb4b3b4393b1a9ca8e1d785091
Autor:
Yu S Milovanov, L Yu Milovanova
Publikováno v:
Терапевтический архив, Vol 84, Iss 6, Pp 48-52 (2012)
Aim. Comparison of efficacy of 12-month treatment of anemia in patients with chronic kidney disease (CKD) of stage III — IV with a long-acting drug darbepoetin alpha — aranesp and short-acting drug erythropoietin beta — recormon. Material and m
Externí odkaz:
https://doaj.org/article/145e62e2c8d54a3a85c79515fad3a5a6
Autor:
Yuriy Sergeevich Milovanov, Lidiya Vladimirovna Kozlovskaya, Lyudmila Yur'evna Milovanova, Yu S Milovanov, L V Kozlovskaya, L Yu Milovanova
Publikováno v:
Терапевтический архив, Vol 83, Iss 6, Pp 70-73 (2011)
Calcitriol is important in nephroprotective strategy in chronic disease of the kidneys (CDK). However, its long-term use often results in hypercalciemia with metastatic calcification. Compared to calcitriol, paricalcitol (zemplar) - metabolite of vit
Externí odkaz:
https://doaj.org/article/6cb462b36f4b429e9cbc217b678d5ebb
Publikováno v:
Терапевтический архив, Vol 82, Iss 6, Pp 66-72 (2010)
The paper deals with the analysis of studies of the role of the bone morphogenetic proteins fibroblast growth factor 23 (FGF-23) and Klothno in the development of vascular wall calcification in chronic renal disease (CRD). FGF-23 is shown to be an im
Externí odkaz:
https://doaj.org/article/3df07b7761444d7293621f86e876c764
Autor:
Yuriy Sergeevich Milovanov, Lidiya Vladimirovna Lysenko, Lyudmila Yur'evna Milovanova, Igor' Aleksandrovich Dobrosmyslov, Yu S Milovanov, L V Lysenko, L Yu Milovanova, I A Dobrosmyslov
Publikováno v:
Терапевтический архив, Vol 81, Iss 8, Pp 52-57 (2009)
Aim. To evaluate the effects of low-protein diet (LPD) balanced by addition of highly energetic mix and essential keto/amino acids on inhibition of renal failure in patients with systemic diseases with predialysis stages of chronic disease of the kid
Externí odkaz:
https://doaj.org/article/8f24fcd8b90a4bc3a5a667a3bf9c72d0